MEP50 is overexpressed in lung, squamous cell carcinoma, and breast cancer at the RNA level [28,29,30] and in ovarian [31], lung [32], and squamous cell [33] carcinomas at the protein level. Here, WDR77 is linked to breast carcinoma.